Private equity owns almost every piece of the US insurance software stack.
Walk through the software stack of a typical US P&C carrier and ask, at each layer, who owns the vendor. The answer in 2026 is almost always a private-equity firm. Five firms now hold most of what a mid-to-tier-1 US insurer actually runs in production.
TL;DR
- Five private-equity firms hold the majority of the US P&C software stack a typical carrier runs.
- Thoma Bravo owns Nearmap (aerial imagery) and historically held other insurtech assets.
- Vista Equity Partners owns Duck Creek Technologies (P&C PAS challenger, $2.6B take-private March 2023) and co-holds EagleView with Clearlake.
- Hellman & Friedman owns Applied Systems (agency management) with CPP Investments.
- KKR formed Enlyte in 2022, consolidating Mitchell, Genex, and Coventry for auto claims + workers' comp.
- GI Partners owns Insurity (specialty-lines PAS + programme business).
- The implications for carriers are concrete: PE ownership brings operational discipline and cash-efficiency focus, often at the expense of aggressive product investment. Multi-year procurement decisions should factor in which vendors are 2-3 years vs 5-7 years into their PE hold.
Walking the stack
Take a mid-to-tier-1 US P&C carrier running a modern stack. Ask: who owns each layer?
Policy admin. Two dominant vendors. Guidewire is publicly traded (NYSE: GWRE) — one of the exceptions in an otherwise PE-dominated landscape. Duck Creek was taken private by Vista Equity Partners at $2.6 billion in March 2023. Secondary options include Insurity (GI Partners) and Majesco (Thoma Bravo, 2020).
Claims admin. Guidewire ClaimCenter (public) vs Duck Creek Claims (Vista Equity). Also Insurity (GI Partners), Origami Risk (VC-backed, one of few not PE-held), and Majesco (Thoma Bravo).
Rating. PAS-native (Guidewire/Duck Creek/Insurity) for most carriers. Specialty pricing platforms: hyperexponential (VC-backed), Akur8 (VC-backed), Earnix (PE-held).
Claims estimating. CCC Intelligent Solutions is publicly traded (NASDAQ: CCCS) — another exception. Mitchell is part of Enlyte (KKR, 2022 consolidation). Solera is PE-held (Vista Equity).
Aerial imagery. Cape Analytics was acquired by Moody's (public) January 2025. Nearmap was taken private by Thoma Bravo at AUD $1.055B December 2022. EagleView is jointly held by Vista Equity Partners and Clearlake Capital since 2018.
Telematics. Cambridge Mobile Telematics (late-stage VC). Arity is an Allstate subsidiary. Zendrive (VC). Samsara is publicly traded (NYSE: IOT) for commercial fleet.
Agency management. Applied Systems is owned by Hellman & Friedman with CPP Investments since 2017. Vertafore was acquired by Roper Technologies (public) in 2020.
Producer compliance. Vertafore Sircon (Roper). AgentSync (VC-backed).
Catastrophe modelling. Moody's RMS (public, post-2021 $2B acquisition). Verisk AIR (public, NASDAQ: VRSK).
At every layer except a handful of public companies (Guidewire, Verisk, CCC, Samsara, Moody's, Lemonade) and a handful of late-stage VC-backed firms, the answer is a private-equity holding.
The five firms you keep running into
Thoma Bravo has been the most active software-focused PE firm in insurance tech over the last decade. Historically held Majesco (2020 acquisition); owns Nearmap (2022, $1.055B AUD take-private); and holds multiple other insurtech-adjacent assets. Thoma Bravo's hold-period discipline is 5-7 years typical, meaning Nearmap is currently mid-window with a 2027-2029 exit horizon.
Vista Equity Partners took Duck Creek private at $2.6B in March 2023 (year 3 of hold), and co-holds EagleView (since 2018, ~year 8 — late window). Vista's insurance-tech footprint is deepening; the exit-horizon clustering around 2028-2030 is worth watching.
Hellman & Friedman took Applied Systems private in 2017 (with CPP Investments). Now ~year 9 of hold. At this stage either secondary sale to another PE or public re-listing becomes live. Carriers signing multi-year Applied contracts in 2026 should expect ownership-transition questions in 2027-2028.
KKR formed Enlyte in 2022 by consolidating Mitchell (auto claims estimating), Genex (workers' comp medical management), and Coventry (utilization review). KKR's typical hold is 5-8 years; Enlyte is in year 4, mid-window.
GI Partners owns Insurity (specialty-lines PAS + programme business). Strong specialty-lines presence. Mid-cycle hold.
Secondary but still material: Clearlake Capital (EagleView co-holding), Roper Technologies (Vertafore, public-market operator), Accel-KKR (growth investor in FRISS).
Why this matters for 2026 procurement
Pricing discipline changes under PE. The general PE playbook — operational discipline, SaaS gross margin expansion, measured price increases at renewal — applies to insurance software as predictably as elsewhere. Carriers who signed multi-year contracts in pre-PE eras will often see pricing discipline arrive at their first PE-era renewal.
Product investment timing is predictable. PE firms invest most aggressively in product roadmap during years 1-3 of hold (setting up the thesis), slow down investment in years 4-6 (margin expansion phase), and often defer investment in years 6-8 (pre-exit grooming). A carrier buying from a year-7 PE-held vendor should not assume the next 3 years of roadmap will look like the last 3.
Exit-horizon risk. When a PE firm exits, the buyer (strategic acquirer or new PE firm) may want different things. Product roadmap can change materially in the 12-24 months post-transaction. Applied Systems, EagleView, and to a lesser extent Nearmap all sit in "late hold, exit horizon visible" status.
The public exceptions. Guidewire, Verisk, CCC, Samsara, Moody's, and Lemonade run on public-market discipline instead of PE discipline. This is not strictly better (public-market quarterly pressure has its own failure modes), but it is different and more predictable. Carriers evaluating single-vendor concentration should factor in whether their "one vendor to rule the stack" is PE-held or public.
Consequences for three common buyer situations
1. Tier-1 P&C carrier on Guidewire considering adjacent vendor consolidation.
Staying with Guidewire for policy + claims + billing is reasonable because Guidewire's public-market discipline gives the roadmap more predictability than most alternatives. Adding Duck Creek for a specific use case (e.g., commercial lines specialty) means signing into a Vista Equity year-3-of-hold window; the pricing discipline is likely still benign but year-5 will look different.
2. Mid-market carrier replacing legacy PAS.
Duck Creek at year-3 vs Insurity under GI Partners vs Majesco under Thoma Bravo all represent different PE-hold risk profiles. Duck Creek is early-mid hold (product investment phase); Majesco has been under Thoma Bravo for 6+ years (late hold, possible exit soon). The year-of-hold dimension should factor into vendor choice alongside feature fit.
3. MGA or programme-business buyer selecting a platform.
Insurity (GI Partners), Socotra (VC), Accelerant (PE with capacity bundle). The Socotra option is the least PE-concentrated but carries the early-stage execution risk instead. There is no PE-free option if scale and feature maturity are required.
The counterfactual question: would the US insurance stack be better without PE?
Probably not, but it would look different.
PE capital is one of the few structures that can fund $500M-$5B take-private transactions at 7-12x revenue multiples for a business that has a durable customer base but slow top-line growth. That profile — high revenue quality, slow growth, high switching cost — describes most enterprise insurance software. Public markets alone cannot fund this kind of vendor at scale; venture capital cannot either (exit timelines are wrong). PE is the natural capital pool.
The counterfactual — a world without PE as an insurance-software capital pool — would likely have: - More fragmented vendor markets (because consolidation requires the buyout capital) - Less product-roadmap discipline on legacy vendors (because public-company pressure alone is too lumpy) - Slower consolidation in sub-scale adjacencies (because there is no capital for roll-up)
So the question is not "should PE own US insurance software" — the ownership structure is downstream of the economics — but "how should carriers price the fact that it does?"
What a procurement team should actually do
Add a PE-hold-risk dimension to vendor evaluation. For each vendor on the shortlist, document:
- Current owner (PE firm / public / VC / founder).
- Hold start date (when did the current owner acquire the company).
- Expected exit horizon (PE firms typically exit at years 5-7 from initial acquisition; late-hold = higher near-term transition risk).
- Recent product investment signals (new major releases, meaningful hiring, M&A).
- Counter-vendor option (if this vendor's ownership changes in 2-3 years, who is the fallback).
For a 3-year procurement decision signed in 2026, at least one of the vendors on the stack will likely see an ownership change before the contract ends. Planning for that is cheaper than reacting to it.
Closing
PE ownership of the US insurance software stack is a fact, not an anomaly. It reflects how the economics of enterprise insurance software work: durable revenue, slow growth, high switching cost, attractive to buyout capital. The carriers who navigate the next 3 years well will treat vendor PE-hold status as a first-class procurement variable, not a footnote. The ones who ignore it will be surprised by their 2027 renewals.
Frequently asked
Who owns Duck Creek Technologies in 2026?
Vista Equity Partners. Vista took Duck Creek private in March 2023 at a $2.6 billion valuation. Prior to the take-private, Duck Creek traded on NASDAQ under ticker DCT from August 2020.
Is Nearmap publicly traded?
No. Nearmap was taken private by Thoma Bravo in December 2022 at an AUD $1.055 billion valuation. Shares delisted from the ASX on December 16, 2022.
Who owns Applied Systems?
Applied Systems is jointly owned by Hellman & Friedman and CPP Investments since their 2017 take-private. The hold period is approaching year 9 as of April 2026, meaning ownership transition (secondary sale or IPO) is a live possibility in the 2026-2028 window.
What is Enlyte?
Enlyte is the KKR-backed holding company that consolidated Mitchell (auto claims estimating), Genex (workers' comp medical management), and Coventry (utilization review) in 2022. Mitchell operates as an Enlyte product family.
Read next
Sources
- Thoma Bravo Completes Acquisition of Nearmap Ltd — PR Newswire
- Vista Equity Partners Is Buying a Fintech Stock -- What Investors Need to Know — The Motley Fool
- News Analysis: Duck Creek is a Private Company Once Again — Insurance Innovation Reporter
- Enlyte — Enlyte / KKR
- Applied Systems — Applied Systems
- Insurity — Insurity / GI Partners